Techno Medica Co (TSE:6678) Research & Development: 円0 Mil (TTM As of Mar. 2026)


TSE:6678 Techno Medica Co Ltd TSE:6678
84 GF Score
Price 円1,978.00
GF Value 円2,404.61
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is Techno Medica Co Research & Development?

Techno Medica Co TSE:6678 +1.59% 84 Research & Development is 円0 Mil as of Mar. 2026. GuruFocus rates TSE:6678 with a GF Score™ of 84/100 and a GF Value™ of 円2,404.61 (Modestly Undervalued). The stock has 2 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Techno Medica Co's Research & Development for the six months ended in Mar. 2026 was 円0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was 円0 Mil.

Techno Medica Co  (TSE:6678) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Techno Medica Co Research & Development Related Terms

Techno Medica Co Research & Development Historical Data

* Premium members only.

The historical data trend for Techno Medica Co's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Techno Medica Co Research & Development Chart

Techno Medica Co Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Techno Medica Co Semi-Annual Data
Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
TSE:6678
84GF Score
Techno Medica Co Ltd TSE:6678
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Techno Medica Co Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was 円0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of 円0 Mil mean?
Techno Medica Co (TSE:6678) has a Research & Development of 円0 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Techno Medica Co and its competitors.
Is Techno Medica Co's Research & Development too high?
Techno Medica Co's current Research & Development is 円0 Mil. Overall, Techno Medica Co has a GF Score™ of 84/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Techno Medica Co's Research & Development compare to ABT and SYK?
Techno Medica Co's Research & Development of 円0 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Medical Devices & Instruments company?
A good Research & Development depends on the Medical Devices & Instruments industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Techno Medica Co and its competitors. Techno Medica Co's current Research & Development is 円0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Techno Medica Co stock overvalued right now?
Based on GuruFocus' analysis, Techno Medica Co (TSE:6678) is currently considered Modestly Undervalued. The stock's GF Value™ is 円2,404.61, compared to a current price of 円1,978.00 — trading 17.7% below its estimated fair value. The current Research & Development is 円0 Mil. Techno Medica Co's overall GF Score™ is 84/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Techno Medica Co (TSE:6678), the current Research & Development is 円0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Techno Medica Co (TSE:6678) Overvalued in 2026?

Based on GuruFocus' analysis, Techno Medica Co stock appears to be undervalued. The current stock price of 円1,978.00 is trading 17.7% below its estimated GF Value™ of 円2,404.61. GuruFocus considers Techno Medica Co to be Modestly Undervalued.

Key valuation signals for TSE:6678:

  • Research & Development: 円0 Mil
  • GF Value™: 円2,404.61 vs. price of 円1,978.00 (17.7% below fair value)
  • GF Score™: 84/100 with 2 warning signs

No single metric tells the full story. See the TSE:6678 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Techno Medica Co Business Description

Address 5-5-1 Nakamachidai, Tsuzuki-ku, Yokohama, JPN, 224-0041
Techno Medica Co Ltd is engaged in the research, development, manufacturing, and sales of medical and in vitro diagnostic products. The company's products classified under Test Tube preparation systems. Additionally, company also import and export medical equipment and Analytical instrument for clinical examination.
84GF Score

Get the complete analysis for TSE:6678

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円1,978.00
Price
円2,404.61
GF Value